Burzynski Research Institute BZYR
OTC BZYR
$0.01 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Burzynski Research Institute (BZYR) Shares Outstanding (2010 - 2025)

Burzynski Research Institute (BZYR) posted Shares Outstanding (Entity) of $131.4 million for Q4 2025, little changed sequentially from $131.4 million in Q3 2025, and little changed YoY from $131.4 million in Q4 2024.

Burzynski Research Institute (BZYR) Shares Outstanding (2010 - 2025) Analysis & Trends

Burzynski Research Institute has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $131.4 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $131.4 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $131.4 million (changed 0.0% YoY) and the FY2025 annual result came in at $131.4 million, changed 0.0% from the prior year.
  • Shares Outstanding (Entity) held at $131.4 million in Q4 2025 per BZYR's latest filing, from $131.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $131.4 million in Q1 2021 and troughed at $131.4 million in Q1 2021.
  • A 5-year average of $131.4 million and a median of $131.4 million in 2021 frame the typical range for Shares Outstanding (Entity).
  • The widest YoY moves for Shares Outstanding (Entity): up 0.0% in 2021, down 0.0% in 2021.
  • Over 5 years, Shares Outstanding (Entity) stood at $131.4 million in 2021, then changed by 0.0% to $131.4 million in 2022, then changed by 0.0% to $131.4 million in 2023, then changed by 0.0% to $131.4 million in 2024, then changed by 0.0% to $131.4 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $131.4 million, $131.4 million, and $131.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Burzynski Research Institute 1.31 Mn 1.31 Mn - 131.45 Mn

Historic Data

Download Data
DateValue
Nov 30, 2025 131.45 Mn
Aug 31, 2025 131.45 Mn
May 31, 2025 131.45 Mn
Feb 28, 2025 131.45 Mn
Nov 30, 2024 131.45 Mn
Aug 31, 2024 131.45 Mn
May 31, 2024 131.45 Mn
Feb 29, 2024 131.45 Mn
Nov 30, 2023 131.45 Mn
Aug 31, 2023 131.45 Mn
May 31, 2023 131.45 Mn
Feb 28, 2023 131.45 Mn
Nov 30, 2022 131.45 Mn
Aug 31, 2022 131.45 Mn
May 31, 2022 131.45 Mn
Feb 28, 2022 131.45 Mn
Nov 30, 2021 131.45 Mn
Aug 31, 2021 131.45 Mn
May 31, 2021 131.45 Mn
Feb 28, 2021 131.45 Mn